Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.58 and traded as high as C$0.58. Acasti Pharma shares last traded at C$0.58, with a volume of 2,450 shares.
Acasti Pharma Price Performance
The stock’s 50 day simple moving average is C$0.58 and its two-hundred day simple moving average is C$0.58. The firm has a market cap of C$18.19 million, a P/E ratio of -1.21 and a beta of 1.22.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Read More
- Five stocks we like better than Acasti Pharma
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
